2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial

Eva-Maria Willing; Claudia Vollbrecht; Christine Voessing; Peggy Weist; Simon Schallenberg; Balazs Jori; Markus Tiemann; Guillaume Bataillon; Philipp Harter; Sandro Pignata; Antonio Gonzales Martin; Ignace Vergote; Nicoletta Colombo; Christian Marth; Tobias Berg; Bettina Kah; Johanna Herbst; Trine Jakobi Noettrup; Markus Falk; Kathrin Arndt; Isabelle Ray-Coquard; Andreas Polten; Robert Bernstein; Franziska Selzam; Judith Pirngruber; Stefanie Schmidt; Michael Hummel; Jalid Sehouli; David Horst; Elena Ioana Braicu; Eric Pujade Lauraine; Katharina Tiemann; Lukas C Heukamp

doi:10.1136/ijgc-2022-ESGO.791

Article info

Pathology

2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial

Free

Authors

Eva-Maria Willing Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Claudia Vollbrecht Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany PubMed articles Google scholar articles
Christine Voessing Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Peggy Weist Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Simon Schallenberg Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany PubMed articles Google scholar articles
Balazs Jori Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Markus Tiemann Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Guillaume Bataillon Laboratoire de pathologie de l’oncopole-IUCT, Touluose, France PubMed articles Google scholar articles
Philipp Harter Kliniken Essen Mitte, Essen, Germany PubMed articles Google scholar articles
Sandro Pignata Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy PubMed articles Google scholar articles
Antonio Gonzales Martin Medical Oncology Departament, Clinica Universidad de Navarra, Madrid, Spain GEICO, Madrid, Spain PubMed articles Google scholar articles
Ignace Vergote Leuven Cancer Institute, University Hospital Leuven, Leuven, Belgium PubMed articles Google scholar articles
Nicoletta Colombo European Institute of Oncology, Milan, Italy PubMed articles Google scholar articles
Christian Marth Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria PubMed articles Google scholar articles
Tobias Berg Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Bettina Kah Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Johanna Herbst Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Trine Jakobi Noettrup Copenhagen University Hospital, Copenhagen, Denmark PubMed articles Google scholar articles
Markus Falk Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Kathrin Arndt Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Isabelle Ray-Coquard Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon, France ARCAGY-GINECO, Paris, France PubMed articles Google scholar articles
Andreas Polten Agilent Technologies Sales and Services GmbH und Co.KG, Waldbronn, Germany PubMed articles Google scholar articles
Robert Bernstein Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Franziska Selzam Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Judith Pirngruber Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Stefanie Schmidt Institut für Hämatopathologie, Hamburg, Germany PubMed articles Google scholar articles
Michael Hummel Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany PubMed articles Google scholar articles
Jalid Sehouli Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany PubMed articles Google scholar articles
David Horst Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany PubMed articles Google scholar articles
Elena Ioana Braicu Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany ARCAGY-GINECO, Paris, France PubMed articles Google scholar articles
Eric Pujade Lauraine ARCAGY-GINECO, Paris, France PubMed articles Google scholar articles
Katharina Tiemann Institut für Hämatopathologie, Hamburg, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany PubMed articles Google scholar articles
Lukas C Heukamp Institut für Hämatopathologie, Hamburg, Germany Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V., Berlin, Germany PubMed articles Google scholar articles

Citation

Willing E, Vollbrecht C, Voessing C, et al

2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial

International Journal of Gynecologic Cancer 2022;32:A370.

Publication history

First published October 20, 2022.

Online issue publication

October 20, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password